Sangamo Therapeutics
SGMO
#8725
Rank
โ‚ฌ0.14 B
Marketcap
0,43ย โ‚ฌ
Share price
-6.45%
Change (1 day)
-77.61%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -โ‚ฌ97.81 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ32.87 Million. In 2024 the company made an earning of -โ‚ฌ84.56 Million, an increase over its 2023 earnings that were of -โ‚ฌ0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ97.81 Million15.67%
2024 -โ‚ฌ84.56 Million-17.27%
2023 -โ‚ฌ0.11 Billion-40.88%
2022 -โ‚ฌ0.18 Billion9.79%
2021 -โ‚ฌ0.16 Billion41.52%
2020 -โ‚ฌ0.12 Billion23.17%
2019 -โ‚ฌ90.34 Million36.33%
2018 -โ‚ฌ66.27 Million36.89%
2017 -โ‚ฌ48.41 Million-22.32%
2016 -โ‚ฌ62.33 Million54.86%
2015 -โ‚ฌ40.25 Million75.62%
2014 -โ‚ฌ22.92 Million0.13%
2013 -โ‚ฌ22.89 Million
2011 -โ‚ฌ30.77 Million43.66%
2010 -โ‚ฌ21.42 Million28.52%
2009 -โ‚ฌ16.67 Million-23.55%
2008 -โ‚ฌ21.8 Million2.45%
2007 -โ‚ฌ21.28 Million19.5%
2006 -โ‚ฌ17.81 Million50.78%
2005 -โ‚ฌ11.81 Million75%
2004 -โ‚ฌ6.75 Million-33.25%
2003 -โ‚ฌ10.11 Million-62.27%
2002 -โ‚ฌ26.8 Million102.82%
2001 -โ‚ฌ13.21 Million23.21%
2000 -โ‚ฌ10.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚ฌ8.49 B-9,167.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ0.11 B-219.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.08 B-7,661.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ1.63 B-1,846.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-โ‚ฌ0.64 Billion 582.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ27.82 B-29,814.01%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.58 B-723.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ19.83 B-21,278.43%๐Ÿ‡บ๐Ÿ‡ธ USA